Literature DB >> 17173250

Relationship of chronic kidney disease to cardiovascular death and myocardial infarction following coronary stenting.

David M Charytan1, Richard E Kuntz, Amit Chhabra, Donald E Cutlip.   

Abstract

BACKGROUND: Chronic kidney disease is a risk factor for death in the year following myocardial infarction or coronary angioplasty. Whether the risk is similar after coronary stenting, whether impaired renal function is associated with an increased risk of cardiovascular death or myocardial infarction (MI) after coronary stenting and whether this risk is maintained beyond the first year are uncertain.
METHODS: We analyzed the long-term risks of MI or the combination of cardiovascular death and non-fatal MI in patients participating in 4 coronary stenting trials with mandated, prospective long-term follow-up. Cox proportional hazards models were used to adjust for confounding and to generate multivariable odds ratios.
RESULTS: Patients (n=1,228) were followed for a median of 5 years. There were 125 MIs and 55 cardiovascular deaths. Patients with a serum creatinine>or=1.3 mg/dL had markedly elevated risks of cardiovascular death and MI that emerged during the first year and were maintained throughout follow-up. The adjusted hazard ratio of MI was 2.14 (p=0.006) while the adjusted hazard ratio of a combined end point of MI or cardiovascular death was 2.13 (p=0.001). The risks were similar in patients with moderate (serum creatinine 1.3-1.9 mg/dL) or advanced chronic kidney disease.
CONCLUSIONS: The presence of even mild chronic kidney disease is associated with a high risk of cardiovascular death and MI following coronary stenting. Further research to address the causes of the association and to define the best therapy for these patients is necessary.

Entities:  

Mesh:

Year:  2006        PMID: 17173250      PMCID: PMC4398775     

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  35 in total

1.  Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries.

Authors:  D S Baim; D E Cutlip; M Midei; T J Linnemeier; T Schreiber; D Cox; D Kereiakes; J J Popma; L Robertson; R Prince; A J Lansky; K K Ho; R E Kuntz
Journal:  Am J Cardiol       Date:  2001-01-15       Impact factor: 2.778

2.  Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.

Authors:  D E Cutlip; D S Baim; K K Ho; J J Popma; A J Lansky; D J Cohen; J P Carrozza; M S Chauhan; O Rodriguez; R E Kuntz
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

3.  Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.

Authors:  Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E De Jong
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

4.  Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting.

Authors:  R R Azar; R Prpic; K K Ho; F J Kiernan; S J Shubrooks; D S Baim; J J Popma; R E Kuntz; D J Cohen
Journal:  Am J Cardiol       Date:  2000-09-01       Impact factor: 2.778

5.  Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction.

Authors:  J N Beattie; S S Soman; K R Sandberg; J Yee; S Borzak; M Garg; P A McCullough
Journal:  Am J Kidney Dis       Date:  2001-06       Impact factor: 8.860

6.  Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.

Authors:  Ronald M A Henry; Piet J Kostense; Griët Bos; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Lex M Bouter; Coen D A Stehouwer
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

Review 7.  Novel cardiovascular risk factors in end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

8.  A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease.

Authors:  Julie Lin; Eric L Knight; Mary Lou Hogan; Ajay K Singh
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

9.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

10.  Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.

Authors:  Jassim Al Suwaidi; Donal N Reddan; Kathryn Williams; Karen S Pieper; Robert A Harrington; Robert M Califf; Christopher B Granger; E Magnus Ohman; David R Holmes
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.